News

Filter

Current filters:

Infergen

1 to 9 of 43 results

Three Rivers finalizes acquisition of Infergen from Valeant

21-01-2008

Three Rivers Pharmaceuticals has finalized its acquisition of the hepatitis C drug Infergen (interferon-alpha)…

AlphaAmgenInfergenInterferon Alfacon-1ProlastinValeant Pharmaceuticals

Valeant sells hep C drug to Three Rivers for $70.8 million plus

07-01-2008

Valeant Pharmaceuticals International has signed a definitive agreement to divest the US and Canadian…

AlphaAmgenInfergenInterferon Alfacon-1ProlastinValeant Pharmaceuticals

Valeant slumps into 3rd-qtr $12M loss

12-11-2007

California, USA-based drugmaker Valeant Pharmaceuticals says that problems with its distribution chain…

CopegusEldeprylInfergenInterferon Alfacon-1RebetolRibavirinRocheSelegiline HclSelegiline HydrochlorideValeant PharmaceuticalsVirazoleZelapar

Stock Commentary - New York week to Nov 5, 2007

12-11-2007

NEW YORK: equities moved up and down - though mostly the latter, in the reporting week to November 5,…

bortezomibCopegusInfergenInterferon Alfacon-1RebetolRibavirinRocheVelcadeVirazole

Valeant reports strong 48-week data for Infergen

06-11-2006

The USA's Valeant Pharmaceuticals presented encouraging 48-week data from a trial of its hepatitis C…

CopegusInfergenInterferon Alfacon-1RebetolRibavirinRocheValeant PharmaceuticalsVirazole

Valeant 1st-qtr 2006 loss deepens to $6.4M

15-05-2006

USA-based Valeant Pharmaceuticals says that, in the first quarter of 2006, revenues increased 10% on…

CesametCopegusEfudexfluorouracilInfergenInterferon Alfacon-1Nabilone CapsulesRebetolRibavirinValeant PharmaceuticalsVirazole

1 to 9 of 43 results

COMPANY SPOTLIGHT

Menarini

Back to top